GABA-A alpha5 cognitive enhancers: pharmacology and neuropsychology in macaques
GABA-A α5 认知增强剂:猕猴的药理学和神经心理学
基本信息
- 批准号:7486744
- 负责人:
- 金额:$ 38.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAgeAgonistAlzheimer&aposs DiseaseAreaAttenuatedBasic ScienceBehavioralBenzodiazepine ReceptorBenzodiazepinesBinding SitesBiological AssayBrainCardiovascular systemCaringCholinergic AgentsClassClinicalCognitionCognitiveComplexDevelopmentDevicesDimensionsDiseaseDoseEconomicsEffectivenessEvaluationFamilyHippocampus (Brain)Impaired cognitionImpairmentImplantIn VitroIonsLaboratoriesLigandsMacacaMacaca mulattaMeasuresMediatingMemoryMinorMonkeysMusNeuroanatomyNeuropharmacologyNeuropsychological TestsNeuropsychologyNootropic AgentsOrganOutcomePalliative CarePathologistPatientsPerformancePharmacologyPopulationPrimatesQuality of lifeRadioRangeResearchResearch PersonnelRodentRodent ModelSamplingScopolamineSiteSpecificityStructureTechniquesTelemetryTestingTherapeuticToxic effectToxicity TestsTrainingTranslational ResearchTreatment CostUnited Statescholinergiccognitive functioncohortcookingcostdirect applicationexperiencegamma-Aminobutyric Acidimprovedin vivoinnovationinterdisciplinary approachmild neurocognitive impairmentneuropsychologicalnonhuman primatenovelprogramsreceptorrespiratoryresponse
项目摘要
DESCRIPTION (provided by applicant): Cognitive impairment is a debilitating outcome of Alzheimer's Disease and Minor Cognitive Impairment. Cognitive impairment reduces quality of life and increases treatment costs. Relatively modest increases in cognitive function produce relatively large increases in quality of life and large decreases in cost of care. Palliative treatments enhancing cognitive function would benefit many patients until treatments for their underlying disorders are developed. One promising pharmacological target for such cognitive enhancers is the benzodiazepine (BZ) binding site on the gamma-aminobutyric acid (GABA) type A (GABAA) receptor- complex. Subtype-selective ligands have been developed for the GABAA-a5 BZ receptor (GABAAa5- BZr), which is predominately expressed in the hippocampus, a site important for memory function. Studies in rodent and nonhuman primate memory assays indicate that GABAAa5-BZr inverse agonists improve cognition with few adverse effects. In the proposed studies, 8 rhesus monkeys will be trained to perform tests from the CANTAB nonhuman primate neuropsychological testing battery. 4 monkeys will be also be trained on the delayed-match-to- sample test and implanted with radio-telemetry devices to measure cardiovascular and respiratory responses for dose-ranging studies. The dose-ranging cohort will determine active doses of the compounds in primates and also screen for compounds producing adverse effects prior to full cognitive testing in the CANTAB-trained monkeys. Novel compounds will be tested for toxicity in mice prior to testing in the dose- ranging or CANTAB-trained monkeys. The effects of GABAAa5-BZr ligands on cognitive function in macaques will be determined by pretreatments of GABAAa5-BZr agonists, antagonists and inverse agonists. These studies will test the hypothesis that activity at the GABAAa5-BZr can bi-directionally modulate cognition with agonists impairing cognitive performance and inverse agonists enhancing performance. The regional specificity of the CANTAB neuropsychological test battery will also allow for testing of the hypothesis that GABAAa5-BZr cognitive modulation will occur in tests mediated by temporal brain structures (i.e. the hippocampus) as opposed to tests mediated by frontal cortical structures. In addition, the ability of GABAAa5-BZr inverse agonists to reverse scopolamine-induced cognitive impairment will determine the potential effectiveness of these compounds as treatments for the cognitive impairment produced by Alzheimer's disease. Understanding the effects of GABAAa5-BZr ligands has important implications to the neuro- pharmacology, neuropsychology and neuroanatomy of cognition and will further development of a novel class of therapeutics for cognitive dysfunction in Alzheimer's disease and Minor Cognitive Impairment.
描述(由申请人提供):认知障碍是阿尔茨海默病和轻微认知障碍的一种使人衰弱的结果。认知障碍会降低生活质量并增加治疗费用。认知功能相对适度的提高会带来相对较大的生活质量提高和护理费用的大幅降低。在开发出针对其潜在疾病的治疗方法之前,增强认知功能的姑息治疗将使许多患者受益。这种认知增强剂的一个有前景的药理学靶点是γ-氨基丁酸(GABA)A 型(GABAA)受体复合物上的苯二氮卓(BZ)结合位点。已经为 GABAA-a5 BZ 受体 (GABAAa5-BZr) 开发了亚型选择性配体,该受体主要在海马体中表达,海马体是记忆功能的重要部位。啮齿类动物和非人类灵长类动物记忆测定研究表明,GABAAa5-BZr 反向激动剂可改善认知能力,且副作用很少。在拟议的研究中,将训练 8 只恒河猴进行 CANTAB 非人类灵长类神经心理学测试电池的测试。 4 只猴子还将接受延迟样本匹配测试的训练,并植入无线电遥测设备,以测量心血管和呼吸系统反应,以进行剂量范围研究。剂量范围队列将确定灵长类动物中化合物的活性剂量,并在对 CANTAB 训练的猴子进行全面认知测试之前筛选产生副作用的化合物。在对剂量范围或经过 CANTAB 训练的猴子进行测试之前,将先在小鼠中测试新型化合物的毒性。 GABAAa5-BZr 配体对猕猴认知功能的影响将通过 GABAAa5-BZr 激动剂、拮抗剂和反向激动剂的预处理来确定。这些研究将检验以下假设:GABAAa5-BZr 的活动可以双向调节认知,激动剂会损害认知表现,反激动剂会增强表现。 CANTAB 神经心理学测试组的区域特异性还将允许测试以下假设:GABAAa5-BZr 认知调节将发生在由颞脑结构(即海马体)介导的测试中,而不是由额叶皮层结构介导的测试中。此外,GABAAa5-BZr反向激动剂逆转东莨菪碱诱导的认知障碍的能力将决定这些化合物作为治疗阿尔茨海默病引起的认知障碍的潜在有效性。了解 GABAAa5-BZr 配体的作用对认知的神经药理学、神经心理学和神经解剖学具有重要意义,并将进一步开发一类治疗阿尔茨海默病和轻微认知障碍认知功能障碍的新型疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nancy A. Ator其他文献
Behavioral Biology
- DOI:
10.1007/bf03391936 - 发表时间:
2017-06-01 - 期刊:
- 影响因子:3.800
- 作者:
Nancy A. Ator - 通讯作者:
Nancy A. Ator
The influence of stimulus uncertainty and experimental instructions on visual selection
- DOI:
10.3758/bf03209542 - 发表时间:
1969-05-01 - 期刊:
- 影响因子:1.700
- 作者:
Terry T. Faw;Jum C. Nunnally;Nancy A. Ator - 通讯作者:
Nancy A. Ator
Nancy A. Ator的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nancy A. Ator', 18)}}的其他基金
The reinforcing and discriminative stimulus effects of orally administered MDMA
口服 MDMA 的强化和歧视刺激作用
- 批准号:
7371392 - 财政年份:2008
- 资助金额:
$ 38.65万 - 项目类别:
The reinforcing and discriminative stimulus effects of orally administered MDMA
口服 MDMA 的强化和歧视刺激作用
- 批准号:
8261993 - 财政年份:2008
- 资助金额:
$ 38.65万 - 项目类别:
FUNCTIONAL ANALYSIS OF GABAERGIC SEDATIVE/ANXIOLYTICS
伽巴能镇静/抗焦虑药的功能分析
- 批准号:
7716156 - 财政年份:2008
- 资助金额:
$ 38.65万 - 项目类别:
The reinforcing and discriminative stimulus effects of orally administered MDMA
口服 MDMA 的强化和歧视刺激作用
- 批准号:
7817121 - 财政年份:2008
- 资助金额:
$ 38.65万 - 项目类别:
The reinforcing and discriminative stimulus effects of orally administered MDMA
口服 MDMA 的强化和歧视刺激作用
- 批准号:
7616801 - 财政年份:2008
- 资助金额:
$ 38.65万 - 项目类别:
The reinforcing and discriminative stimulus effects of orally administered MDMA
口服 MDMA 的强化和歧视刺激作用
- 批准号:
8067923 - 财政年份:2008
- 资助金额:
$ 38.65万 - 项目类别:
GABA-A alpha5 cognitive enhancers: pharmacology and neuropsychology in macaques
GABA-A α5 认知增强剂:猕猴的药理学和神经心理学
- 批准号:
7916676 - 财政年份:2007
- 资助金额:
$ 38.65万 - 项目类别:
GABA-A alpha5 cognitive enhancers: pharmacology and neuropsychology in macaques
GABA-A α5 认知增强剂:猕猴的药理学和神经心理学
- 批准号:
7675260 - 财政年份:2007
- 资助金额:
$ 38.65万 - 项目类别:
GABA-A alpha5 cognitive enhancers: pharmacology and neuropsychology in macaques
GABA-A α5 认知增强剂:猕猴的药理学和神经心理学
- 批准号:
8132922 - 财政年份:2007
- 资助金额:
$ 38.65万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 38.65万 - 项目类别:
Directed Grant